肝动脉插管化疗栓塞术治疗原发性肝癌临床疗效分析

doi:10.3969/j.issn.1672-5069.2015.02.024

Abstract

Xu Dong, Yuan Weidong. Clinical efficacy of hepatic artery chemoembolization in the treatment of patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(2): 195-196.

[1] 张世斌. 肝动脉栓塞化疗联合射频消融治疗原发性肝癌的临床观察. 中国肿瘤临床与康复,2014,21（5）:576-578.
[2] Anwar SL,Lehmann U. DNA methylation,microRNAs,and their crosstalk as potential biomarkers in hepatocellular carcinoma.World J Gastroenterol,2014,20（24）:7894-7913.
[3] Chen JD1,Xiong YQ,Dong K.Clinical significance of joint detection of serum VEGF,SIL-2R and HGF in patients with primary hepatocellular carcinoma before and after percutaneous microwave coagulation therapy. Asian Pac J A cancer Prev,2014,15（11）:4545-4548.
[4] Carr BI,Bron K,Swanson DP. Prospective randomized trial of hepatic artery chemotherapy with cisplatin and doxorubicin,with or without lipiodol in the treatment of advanced stage hepatocellular carcinoma. J Clin Gastroenterol,2011,45（9）:e87-91.
[5] 朱介宾,肖亦明,孔宪和,等. 肝动脉栓塞术联合艾迪注射液与替比夫定治疗晚期原发性肝癌50例. 医药导报,2012,31（1）:25-27.
[6] Zurkiya O,Ganguli S. Beyond hepatocellular carcinoma and colorectal metastasis:the expanding applications of radioembolization. Front Oncol,2014,4:150.
[7] 姚晖,龚金兰,李莉,等. 立体定向放疗联合高强度聚焦超声治疗原发性肝癌的临床研究. 实用癌症杂志,2014,29（1）:29-32,50.
[8] Del Prete M,Fiore F,Modica R,et al. Hepatic arterial embolization in patients with neuroendocrine tumors.J Exp Clin Cancer Res,2014,33（1）:43.
[9] van Lienden KP,Hoekstra LT,van Trigt JD,et al. Effect of hepatic artery embolization on liver hypertrophy response in a rabbit liver VX2 tumor model. Hepatobiliary Pancreat Dis Int,2013,12（6）:622-629.
[10] 蒋明,马华兵,杨瑞梅,等. 肝动脉化疗栓塞治疗原发性肝癌200例分析. 当代医学,2012,18（27）:70-71.
[11] Terlizzi JP,Azizi R,Chow MD,et al. Peliosis hepatis in a child with myotubular myopathy:successful treatment using hepatic artery embolization. J Pediatr Surg,2013,48（8）:e9-e12.
[12] Ong CC1,Toh L,Lo RH,et al. Primary hepatic artery embolization in pediatric blunt hepatic trauma. J Pediatr Surg,2012,47（12）:2316-2320.

[1]	Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[5]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[6]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[7]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[8]	Feng Wenguang, Jiang Wei, Song Guojun.. PPV-guided fluid therapy in patients with hepatolithiasis underwent partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(6): 912-915.
[9]	Li Qiuxi, Jia Jianfeng, Huang Rui.. Clinical value of segmental pedicle hepatectomy and B-ultrasound-guided hepatectomy in the treatment of patients with hepatolithiasis [J]. Journal of Practical Hepatology, 2019, 22(6): 916-919.
[10]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[11]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[12]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.
[13]	Zhang Xu Lei, Yang Qingyu, Han Qiuyu, et al. Short-term efficacy of herbal medicine in treatment of patients with nonalcoholic fatty liver disease [J]. Journal of Practical Hepatology, 2019, 22(5): 660-663.
[14]	Song Haiyan, Chen Xi, Zhang Junfei, et al. Application of vorionazole in the treatment of patients with liver failure complicated by pulmonary fungal infection [J]. Journal of Practical Hepatology, 2019, 22(5): 676-679.
[15]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.

Clinical efficacy of hepatic artery chemoembolization in the treatment of patients with primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments